Amyloidosis and female protein in the Syrian hamster. Concurrent regulation by sex hormones by unknown
AMYLOIDOSIS AND FEMALE PROTEIN
IN THE SYRIAN HAMSTER
Concurrent Regulation by Sex Hormones
By JOHN E. COE AND MARY JANE ROSS
From the National Institutes of Health, National Institute ofAllergy and Infectious Diseases,
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories,
Hamilton, Montana 59840
Amyloid is apathological deposit ofhighly ordered proteinaceous material found
in tissues of man and many animals (for review see references 1, 2). Congophilia
and green birefringence are diagnostic histological features ofamyloid and arecaused
by the fibril component that is arranged as a (3-pleated sheet and characteristically
resistant to proteolysis and insoluble in physiological solution. The fibril is the ma-
jor component, and in human amyloidosis, the fibril can be derived from a variety
ofserum precursor proteins such as IgL chain, prealbumin, a2-microglobulin, and
calcitonin. In reactive or secondary amyloidosis ofhumans, the fibril is composed
ofanother protein called amyloid A (AA)' protein, derived from a putative precur-
sor serum protein, apo SAA (3); a similar homologous AA protein is responsible
for the fibril component in animal models ofamyloidosis except in the senescence-
accelerated mouse (4). In most instances the pathogenesis of amyloid has been re-
lated to the abnormal expression and accumulation of the serum fibril precursor,
which can be either an aberrant protein oranormal protein with excessive synthesis
or altered metabolism. In addition to the (3-pleated fibril component, amyloid de-
posits in manand experimental animalsalsocontain anotherminor protein compo-
nent that is called amyloid P component (AP) (5, 6) and is derived from a related
protein in serum called serum AP (SAP). The role of SAP in amyloid formation
is unknown. SAP binds to the fibril in calcium dependent fashion (7), and by this
means SAP may simply accumulate in amyloid as a secondary event. However, in
the presence ofcalcium, SAPhas been observed to form orderedstructuresby itself,
so that a primary framework role for fibril assembly was proposed for this ubiqui-
tous although minor constituent ofamyloid (8). Nevertheless, there islittle evidence
that SAP actively contributes in a primary fashion to the pathogenesis ofamyloid,
except for a recent report on amyloidosis of humans (9) where a genetic marker
5' to the SAP gene was linked to a predisposition for reactive amyloidosis injuvenile
arthritis.
Amyloidosis in the Syrian hamsteris a model in which SAP rather than the fibril
precursor may play a critical role in the sex-limited expression of amyloid. In this
I Abbreviations used in this paper: AA, amyloid A protein; AEF, amyloid-enhancing factor; AP, amy-
loid P component; DES, diethylstilbestrol; FP, female protein; SAA, serum amyloid A protein; SAP,
serum amyloid P component.
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species, the homologue of SAP is under sex hormone control so that female ham-
sters expresslarge amounts (1-3 mg/ml serum) ofthis protein, called female protein
(FP), and serum levels in males are 100-200-fold lower (usually <0.005 mg/ml) (10).
From metabolic and mRNA data, these serum levels reflect the relative differences
in hepatic synthesis of FP by male and female hamsters (11, 12). Previous studies
showed that FP functions like ahamster SAP because FP was found to be aconstitu-
ent of hamster amyloid, and plasma metabolism of 125I-FP was altered in a diag-
nostic manner in the amyloidotic hamster (13). Although FP is apparently only a
minor constituent of amyloid similar to SAP in other species, amyloid deposition
is directly related to the high serum levels of FP found in the aging normal female
or in the estrogen-treated male (13). Serum levels of FP can be markedly changed
in male or female hamsters by exogenous sex steroids. Therefore, this hamster amy-
loid model provides a unique opportunity to hormonally manipulate the synthesis
of one component of amyloid, the SAP homologue, and determine if high rates of
FP production are important for amyloid formation. In the present report, the down-
regulating effects of testosterone on FP synthesis are used to modulate serum levels
of this SAP homologue in male and female hamsters . The results herein substanti-
ate a concurrence between FP synthesis and amyloidosis, indicating that excessive
FP production plays a critical role in deposition of amyloid in the Syrian hamster.
Materials and Methods
Animals.
￿
Randomly bred Syrian hamsters (Mesocricetus auratus) were obtained from Rocky
Mountain Laboratoryhamster colony and were fed Purina Laboratory Chow and water ad lib.
Histologic Procedures.
￿
Tissue from necropsy was examined after sectioning of frozen tissue
or of formalin-fixed, paraffin-embedded material. The histologic procedures and the histo-
logic distribution and quantification of amyloid were previously described (13). Also in this
study small pieces of fresh tissue from necropsy were squashed between microscope slides
and then fixed and stained. Congo red staining (14) was done on histologic sections and on
squash preparations ofliver, spleen, and kidney and these were examined for typical birefrin-
gence by polarization microscopy. If any organ contained detectable amyloid, the animal
was counted as amyloidotic; kidney was frequently the last organ to develop detectable amy-
loid. As a rough quantification of the amount of amyloid in a squash preparation, the ratio
of birefringent material to normal tissue was graded from 1 ` (minimal birefringence found
in <1% of tissue area) to 4' (maximal birefringence found in >25% of tissue area).
Amyloid Experiments.
￿
Male Syrian hamsters under pentobarbital or ether anesthesia were
castrated by excision of the testicle after ligation of spermatic cord. Various modes of long-
term testosterone administration were tried; testosterone (Sigma Chemical Co., St. Louis,
MO) was administered as a pellet (Innovative Research of America, Toledo, OH) or as con-
tents of a silastic tube (Dow-Corning, Midland, MI) 1.47 mm ID, 25 or 50 mm long, which
was closed at both ends by silastic medical adhesive (Dow-Corning) cement. Silastic bags,
testosterone pellets, diethylstilbestrol (DES) pellets, (15 mg, Pellestrol; Franklin Laborato-
ries, Denver, CO) and a zearalenol pellets (12 mg, Ralgro; Pitman-Moore, Terre Haute, IN)
were surgically implanted subcutaneously in ether anesthetized animals; their presence was
verified by gross observation at necropsy. Hamsters, under ether anesthesia, were bled from
retro-orbital plexus and serum FP levels were determined by ring diffusion assay as before
(10). Because amyloid normally accumulates in the agingSyrian hamster (female >>> male),
the animals were routinely 3 mo of age on day 0 of the experiment unless otherwise noted.
In each experiment, serum FP levels were monitored at least monthly to determine effective-
ness of hormone treatment. In general, pellets and silastic bags provided hormone effect for
3 to 4 mo and in long-term experiments were reimplanted every 3-4 months. The sodium-caseinate(Difco Laboratories, Detroit, MI) was from the same lot as before andprepared/in-
jected as previously described (13).
Statistical analysis used the Fisher Exact Test.
Results
StudiesonAmyloidinMale Syrian Hamsters.
￿
Amyloid is acommon spontaneousdis-
ease in the Syrian hamster and can be found in the female hamster at an earlier
age than in the male hamster (13, 15-22). To determine if testicles are responsible
for this sexdifference inexpression ofamyloid, male Syrian hamsters were castrated
at 6 wk ofage and necropsied 10 mo later (11.5 mo ofage), when spleen, liver, and
kidney were examined for presence of amyloid. Table I compares results from 17
castrated hamsters and 15 control (sham castrated) hamsters. One of 15 controls
showed evidence ofamyloid, a6% incidencesimilar toprevious results with normal
male hamsters (13). In contrast, a significant (p = <0.001) number (15 of 17) ofcas-
trated male hamsters had amyloid deposits, an incidence that was similar to that
of normal 11-mo-old female hamsters (13). After castration, the level of serum FP
rapidly increased, as shown before (23), and at necropsy the average FP concentra-
tionwas0.248 mg/ml in serumofcastrates (vs. 0.002 mg/ml in control serum). Cas-
trated (or estrogen-treated) male hamsters typically achieve a serum FP leyel less
than halfthat ofnormal female hamsters, and serum levels decrease with aging(23).
DES administered to male hamsters promotes deposition of amyloid (13, 15, 20,
24-26). This could be the result ofthe estrogenic properties ofDES or some other
unknown toxicoramyloidogenic effect ofDES. One ofthe known estrogenic effects
ofDES in the male Syrian hamster is involution of testicles with inhibition of tes-
tosterone synthesis, and without testosterone, serum FP promptly increases -50-
fold; the serum FP, response pattern to DES administration is similar to that seen
after castration (23). To determine iftestosterone deficiency is the important com-
ponent forDES induction ofamyloidosis, exogenous testosterone was administered
to some ofthe DES-treated male hamsters and the incidence of amyloid was com-
pared (Table 11). After 6.5 mo of treatment with DES alone, all 23 male hamsters
(100% incidence) showed amyloid deposits. This incidence was significantly (p =
0.002) diminished to 60% (9 positive of 15 examined) when testosterone was also
administered. FP levels were monitored during the course ofthe experiment and
exogenoustestosterone waseffectivein partial (but not complete)suppression ofhigh
FP levels induced by DES. Thus, FP levels were still 10-20-fold higher than normal
Number
of animals
￿
Presence of amyloid
examined
￿
Spleen
￿
Liver
￿
Kidney
￿
Incidenc6
￿
Serum FP at necropsy
Control
￿
15
￿
1
￿
1
￿
1
￿
6%
￿
0.002 (<0.001-0.005)"
Castrated
￿
17
￿
15
￿
14
￿
14
￿
8851 0 ￿0 .248 (0.001-0.670)
Mean (range) mg/ml.
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TABLE I
Incidence ofAmyloid in Male Syrian Hamsters at 11.5 mo of Age
with/without Castration (at Age 6 wk)1260
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in the testosterone-DES group of male hamsters, and the incidence of amyloidosis
(9 of 15) was also significantly (1b = <0.001) greater than that seen in normal con-
trols(3 of 20) (Table II). Quantification ofthe amount of birefringent amyloidpresent
in tissue squash preparations after Congo red staining indicated that the amount
ofamyloid infiltrate in all 23 DES-treated animals was distinctly greater(3-4+) than
that found in the 9 amyloidotichamsters in the DES/testosterone treatedgroup (1-2 +)
(Table II).
In our hands, sodium caseinate injections cause very slow accumulation of amy-
loid in male Syrian hamsters; however, when combined with DES treatment, the
process of amyloid formation is markedly accelerated (13). Usingthis combination
treatment for 4.5 mo, 18 of 21 male hamsters developed amyloid (86%) (necropsy
serum FP average 0.58 mg). Another 21 male hamsters received the same combina-
tion treatment, and in addition, testosterone (silastic bag day 0, day 90); after 4.5
mo amyloid was found in only 2, a significantly (;6 = <0.001) lower 9.5% incidence
(necropsy serum FP level average 0.11 mg/ml). Therefore, testosterone also inhib-
ited amyloid deposition resulting from DESteaseinate treatment.
a Zearalenol is a resorcylic acid lactone compound that has estrogenic activity
and that alters hepatic FP synthesis after injection into Armenian hamsters (our
unpublished data). When three pellets (12 mg each) were injected into 10 male Syr-
ian hamsters (on day 0, day 90), serum FP levels did not significantly increase, and
after 5.5 mo of treatment all animals were histologically negative for amyloid by
pathological examination. Thus, zearalenol is an example of an estrogen that does
not increase FP synthesis or enhance amyloid formation in male Syrian hamsters.
Studies on Amyloid in Female Syrian Hamsters.
￿
The normal female Syrian hamster
can acquire amyloid at ayounger age and in greater quantity than the normal male
hamster; in the RML hamster colony, amyloid is detectable in most normal female
hamsters that are more than 1 yr old (13). The 100-200-fold greater levels of serum
FP in female as compared with male hamsters can be lowered in female hamsters
by treatment with testosterone. To determine if female hamsters with low FP levels
acquired less amyloid with aging, testosterone was administered on along-term ba-
sis to otherwise normal female hamsters, and they were killed at various ages to de-
termine at what age amyloidosis was first detected. Fig. 1 shows results of an experi-
ment in which 2-mo-old female hamsters were implanted with silastic bags (with
or without testosterone) on day 0 and reimplanted with similarbags at 4, 6, 10, and
15 mo. Individual hamsters were monitored for serum FP levels during the experi-
ment and groups of animals were necropsied at various times (11, 13, 15, 17, and
21 mo of treatment). Serum FP concentration was suppressed in the testosterone-
treated groups, although FP levels were rarely as low as that found in normal males.
Examination of tissues obtained at necropsy indicated that amyloid was present in
all the control female hamsters after 11 mo or more treatment (13 mo or more of
age); however, no amyloid was found in the testosterone-treated groups after 11 mo
or 13 mo treatment. After 15 mo of treatment (17 mo of age), three of four hamsters
were still nonamyloidotic, and even after 21 mo of treatment (23 mo old) one female
hamster was free of amyloid. Normal female hamsters more than 1 yr old without
detectable amyloiddeposits in liver, spleen, or kidney are rarely found in our colony.
Also, normal female hamsters living 23 mo areunusual, andall of the control group
females were dead by 23 months of age. In addition, there was a distinct differenceCOE AND ROSS
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FIGURE 1 .
￿
Effect ofchronic testosterone treatment on development of amyloid in aging female
Syrian hamsters . On day 0, 2-mo-old female hamsters were given a silastic bag (25 x 1.45 mm)
either containing testosterone (-) or without testosterone, controls (--). A similar silastic bag
was reimplanted subsequently on month 4, 6, 10, and 15 of experiment and individual serum
FP levels were monitored . Groups of experimental and control animals were killed at 11, 13, 15,
17, and 21 mo, and the presence of amyloid in tissues of individual animals was evaluated by
histological examination . Chronic testosterone treatment diminished serum FP, anddiminished
incidence of amyloid in agingfemale hamsters, None of the female control hamsters were alive
after 21 mo of the experiment,
in amount of amyloid in the two groups, with very heavy (4+) amyloid deposit in
all control animals at 15 and 17 months treatment and only lightly positive (1 +)
deposits in amyloid-positive hamsters of the testosterone-treated group, even after
17-21 mo of treatment .
In the previous experiment, testosterone treatment was initiated in young (2-mo-
old) female hamsters . We also tested foreffectiveness of testosteronewhen treatment
was initiated in younger (1-mo-old) and older (3-mo-, 5-mo-old) female hamsters
('Ikble III, top), All female hamsters were pathologically examined at 10 mo of age
(5-9 mo of treatment), and amyloid was not detected in any of the 14 testosterone-
treated hamsters . In contrast, a significant (p = <0.001) number, 10 of 17 (59%),
of controls contained detectable amyloid deposits at this age . Thus, testosterone given
from 1 to 5mo of age was effective in retarding the development of amyloidosis in
the aging female hamster.
DES will also enhance amyloidosis when injected into female Syrian hamsters.
Therefore, long-term testosterone treatment was also used in an attempt to protect
the DES-treated female from amyloidosis . The results of four separate experiments
indicated that in the presence of DES, testosterone could still partially suppress se-COE AND ROSS
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TABLE III
Effect of Chronic Testosterone Treatment on Amyloid Development in
Aging and DES-treated Female Syrian Hamster
5 mo (n = 4).
II DES pellet (15 mg) + testosterone bag (25 mm) day 0, implanted in 3-mo-old hamsters.
DES pellet (15 mg) day 0, implanted in 3-mo-old hamsters.
rum FP levels and amyloidosis. Two experiments with similar treatment schedules
are compiled in Table III (bottom); after3 mo oftreatment with DES alone (6 mo
of age), amyloid incidence was 87% (20/23), whereas with additional testosterone
treatment, amyloid incidencewas significantly (p = 0.013)decreased to47% (8/17).
Discussion
When compared with other mammals, Syrian hamsters are unique in the follow-
ingways-, (s) these hamstershave an SAPhomologue (FP)that isundersexhormone
control (10); (b) female hamsters have the highest normal serum concentration of
an SAP homologue, 10-100-fold greater than serum SAP in other mammals (27);
(c) amyloidosis is asex-limited disease, as female hamsters, undernormal orexperi-
mental conditions, can acquire more amyloid at an earlier age than male hamsters
(13, 17, 21, 22); and (d) female hamsters die at an earlier age than male hamsters
(16, 17, 21, 22, 28) due to amyloid accumulations (15, 17, 20, 25), We have specu-
lated that these sex-limited phenomena are related to each other, and that the high
serum-FP level in female Syrian hamsterplays a primary role in amyloid deposition
in Syrian hamster (13), Such an etiology is tenable because only one ofthe amyloid
constituents, FP, is under.sex hormone control. The other component of hamster
amyloid, theAA fibril (20), is presumably derivedfrom serum AA (SAA), and SAA
is not under sex hormonal control as it is expressed equally in male and female Syr-
ianhamster(30; and l)owton, B., personal communication), Thus, sex-related'amy-
loidosis ofSyrian hamstermay representaformofamyloid inwhich overproduction '
ofthe minor amyloid constituent, the SAP homologue, is responsible fordeposition
ofthe mqjarcomponent, theAA fibril. Asreported herein, experimental manipula-
tion ofFP synthesis by hormones provides an opportunity to correlate production
of this SAP homologue with amyloid deposition.
Theinduction ofamyloidbyadministration ofDES (or estrogens)toSyrian ham-
sters (15, 20, 25, 26) is another unique phenomenon that has not been reported in
anyother species. Ourprevious studies confirmed this finding and also showed that
Number of
female Treatment Amyloid incidence Serum FP
hamsters (duration) Age (mo) Spleen Liver Kidney Percent at Necropsy
14 T* (5-9 mo) 10 0 0 0 0 0.16 (0.14-0.4)1
17 C§ (5-9 mo) 10 10 10 9 59% 0.91 (0.49-1 .2)
17 D + T11 (3 mo) 6 8 4 3 47% 0 .3 (0 .15-0.63)
23 DI (3 mo) 6 20 15 11 87% 0.73 (0.23-1 .1)
* Testosterone bag (50 mm) day 0 ( x 2), day 51 ( x 1), implanted at age 1 mo (n = 4), 3 mo (n = 3),
5 mo (n = 7).
1 Mean (range) FP mg/ml .
S Control, plain silastic bag day 0 ( x 2), day 51 ( x 1), implanted at age 1 mo (n = 8), 3 mo (n = 5),1264
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DES markedly enhances serum FP concentration inmale hamsters (13). DES turns
offtestosterone synthesis indirectly via a pituitary inhibition; this "chemical castra-
tion" stimulates FP synthesis in a manner similar to that found after surgical castra-
tion (23). In the present study, testosterone administration abrogated the DES in-
ductionofamyloidin both normal andsodium caseinate-injected male Syrian hamsters
(provided sufficient testosterone was given to suppress serum FP levels). Therefore,
the amyloidogenic effect of DES in male Syrian hamster was related to a paucity
ofendogenous testosterone. Surgical castration also eliminates testosterone in male
Syrian hamsters, and as shown herein, the subsequent increased FP synthesis was
associated with early onset of amyloidosis with aging. Kirkman and Yau (28) ob-
served thatcastration ofmale Syrian hamsters resulted in a shortened life span when
compared with intact male hamsters; they noted that such a result was unusual be-
cause orchiectomy characteristically promotes longevity in mammals. The results
ofthe present study suggestthat the shortened longevity ofcastrated malehamsters
may be related to early onset of amyloidosis in a time frame similar to that found
in normal female Syrian hamsters. Not all estrogens have this amyloidogenic effect
in male Syrian hamster because a zearalenol, a resorcylic acid lactone compound
(31), does not promote amyloid deposition in hamsters. This may be explained by
the finding that a zearalenol also does not cause testicular involution or cause in-
creased serum levels ofFP in male Syrian hamster, although zearalenol does affect
FP synthesis in other hamsters such as Armenian hamster(our unpublished data).
Testosterone alsoinhibitedamyloid accumulations infemale Syrian hamsters, pro-
vided that sufficient amounts were givento depress serum FP levels. In DES-treated
female hamsters, large amountsoftestosterone produced onlypartial(20-50%) sup-
pression ofFP serum levels and only partial suppression ofamyloid. However, tes-
tosterone treatment ofotherwise normal female hamsters was more effective in low-
eringserum FPlevels anddecreasingamyloid accumulation with aging. Underchronic
testosterone treatment alone, all treated female hamsters remained free of amyloid
until >14 mo ofage and individual 18- and 22-mo-old female hamsters were found
tobe negative for amyloid. This is a remarkable eventconsidering that in our ham-
stercolony, amyloid isconsistently found innormal female hamsters >1 yr old. These
treated female hamsters alsolived longer thanfemale controls, indicatingthat chronic
testosterone treatment enhanced longevity of female Syrian hamsters.
Testosterone treatment also limited amyloidosis when started in 1-, 2-, or 5-mo-
old females. Preliminary data suggest that a slightly lower level of serum FP may
be attained by earlier testosterone treatment offemale hamsters. Attempts to actu-
ally reverse the deposition ofamyloid by loweringserum FP levels are currentlyun-
derinvestigation. However, this experimentrequires amore precise method to quan-
tifyamyloid intissues than therough estimate used occasionally in the present study.
In this report, examinations for amyloid were performed at a time when a posi-
tive/negative difference in detectable amyloid waspresent in experimental and con-
trol groups sothat quantification was not necessary. However, the rough quantification
used occasionally herein was valid due to large differences between groups; for ex-
ample, when the testosterone-treated female hamsterdevelopedamyloid, the depos-
its were markedlylessthan normal female hamsters ofthe same age withhigh levels
of FP.COE AND ROSS
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High FP serum concentration is associated with amyloid deposition; however, it
does not appear tobe the only factor responsible foramyloidosis ofthe Syrian ham-
ster. Forexample, DES is quite amyloidogenic when administered to male hamster
but also promotes amyloidosis in female Syrian hamsters, and this occurs without
a detectable increase in serum levels ofFP; indeed, a modest decrease in serum FP
concentration may occur in DES-treated female hamsters (our unpublished data).
We havenot eliminated the possibilitythat DES inthe female hamstermay produce
changes in metabolism ofFP that are more conducive to amyloidosis. Other factors
to consider are the amyloid-promoting factors that have been described in mouse
(32) and hamster (33) models. These amyloid-enhancing factors (AEF) are very
efficient (injection of relatively small amounts induce amyloid deposits detectable
within a few days), and accordingly differ from normal serum FP that is associated
with amyloidosis after months of high serum levels. Also, injections of native FP
into hamsters have not induced amyloidosis in an AEF fashion (our unpublished
results), although a degradation product of FP with characteristics ofan enhance-
ment factor has not been ruled out. Finally, the Syrian hamster itself must be con-
sidered because this species appears to have a peculiar propensity for amyloidosis;
although this disease is especially prominent in female hamsters, it is also found
in normal aging male hamsters with low levels of serum FP (13). In other hamster
speciesamyloid deposits are very rare. Forexample, theArmenian hamsteralso has
a circulating female protein, with levels 10-fold greater than those found in the se-
rum ofmale Syrian hamsters, yet amyloidosis is not found in the aging (and long-
lived) Armenian hamster (our unpublished data).
Awide variety ofpathophysiological events have been cited as etiologic in amy-
loidosis. This disease is certainly multifactorial also in the Syrian hamster; however,
the unique sex association of amyloid in this species indicates that sex hormones
are etiologically important and, as shown herein, testosterone does diminish amy-
loidosis presumably by decreasing synthesis ofFP, a minor constituent ofamyloid.
Excessive synthesis of FP, the P component homologue, is a critical factor for the
deposition of amyloid in the aging Syrian hamster.
Summary
Previous results have shown thatwhen compared to male Syrian hamsters, female
Syrian hamsters have a distinct predisposition to acquire amyloidosis either nor-
mallywithagingorexperimentally with sodium caseinateordiethylstilbestrol (DES)
treatments. In the present study, we tested the influence oftestosterone on expres-
sion ofamyloid todetermine ifthishormone wassolely responsible forthesex-limited
amyloidosis ofthe Syrian hamster. Males deprived of testosterone by castration ac-
quired amyloid at an unusually young age, an age ofonset similar to that in female
hamsters. Also, the amyloidogenic effect ofDES in male Syrian hamsters wasinhib-
ited byconcomitant injections oftestosterone, indicatingthatestrogensinduce amy-
loid in male hamsters by inhibiting testosterone synthesis. When administered to
female hamsters, testosterone inhibited expression of amyloid in aging female Syr-
ian hamsters and extended the life span ofthis gender. Ofthe two components of
amyloid, the major component Amyloid A-derived fibril or the minorconstituent,
Amyloid P component, only the P component is under sex hormone control in the1266
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Syrian hamster; testosterone inhibits the hepatic synthesis of the P component ho-
mologue (called female protein), which is normally expressed 100-200-fold greater
in female vs. male Syrian hamster. In general, the serum level of female protein un-
der various experimental conditions correlated with the presence of amyloid and
indicated that in the Syrian hamster the P component homologue is of primary im-
portance in the deposition of amyloid.
The authors are grateful to Dr. Bill Hadlow for preparation and examination ofhistological
sections, and to Irene Cook Rodriguez for preparation of manuscript.
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